Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells. - Wikidata - wikimedia - TriplyDB

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

http://www.wikidata.org/entity/Q34629026

about

Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer.Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery.Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses.Opportunities and challenges of radiotherapy for treating cancer.Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

P2860

Q35822102-CD014790-7562-46C3-80F5-8800E44E9ABA Q37070115-046B8587-F878-4105-81CC-9737FB97A045 Q37427124-A0DA2CE3-DC5B-48F0-88E5-6306AAAFF18B Q38539957-96444D58-9A1A-4F80-AC88-C5A9E2C0CD26 Q38759678-2046C7B9-D0D0-43CA-8525-34C20C1B8DC6 Q41026661-D4E0A2B8-901A-4A1A-BEC2-32291CA8EBE5 Q46692312-BA2A2E02-AF5D-40B8-944F-EED28737086A

P2860

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

http://www.wikidata.org/entity/Q34629026

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@ast

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@en

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@nl

type

label

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@ast

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@en

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@nl

prefLabel

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@ast

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@en

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@nl

P1433

Q34629026-0ABAA2A8-2B8A-442A-95A5-235F76C73B58

P1476

Q34629026-B5449834-D712-46BD-8267-734B92704230

P2093

Q34629026-1024BF20-B809-4BBE-9B1B-148E6C4D8C09

Q34629026-436759B7-4628-44CD-913F-343B4AE22CAF

Q34629026-44C6943D-A248-43B2-8E7A-030F23A7455B

Q34629026-8314BE76-3D55-4A18-98B5-A21F75C164E5

Q34629026-9F1FAEB3-B169-41BA-8E61-0DDAC997540D

Q34629026-ED4BF459-6789-4EC9-8341-1D38B73F0FFF

P2860

Q34629026-09F29660-9486-4971-A84E-D0AC76A9188E

Q34629026-104BCD55-D9D4-4DA4-B7DA-C1FD071D1035

Q34629026-16391335-F3A2-4BB7-82A2-890275725986

Q34629026-1A32EB6B-8EF5-4C4E-8BE7-F61248A8D0DB

Q34629026-2613298A-3256-479D-9620-B3450D0195E2

Q34629026-2A5E2F27-226B-4DE8-90AF-60CAAFB3F936

Q34629026-31F6EDC7-CB7E-4990-9976-090013D7D05D

Q34629026-33B2AAE8-5745-47E9-9D8B-2DB604C76663

Q34629026-33ECC65E-924A-4AB9-9F7E-F51FC1CBD5E0

Q34629026-3A77B6CD-C4C7-47AE-A3FB-DA27D956FE4B

P2888

Q34629026-98822B8B-8222-4ADB-91F4-0EB341BC1DF0

P304

Q34629026-1AAFE342-BA7C-4E40-B515-23E82DE57264

P31

Q34629026-61F0107A-4EBA-494B-9F06-B6BED147D360

P356

Q34629026-202CBA19-2B6A-4488-8DED-2DF5EDC6C153

P433

Q34629026-4D4DA074-4252-4C2B-B728-CF9C0E0D9B60

P478

Q34629026-25CF2687-9FA3-4F72-B5B0-6693051FDC02

P577

Q34629026-DE10E367-D2D6-4488-856E-51CEAFEEB240

P698

Q34629026-96B1A55D-2C74-415C-A36D-05EE991100FB

P921

Q34629026-30139371-58AD-4DFD-B654-BC3A98EDA29A

P932

Q34629026-E020E8CB-EA43-4514-8049-5495B2815FA2

P356

S12192-014-0533-4

P1433

Cell Stress & Chaperones

P1476

Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.

@en

P2093

Hyung-Joo Kwon

http://www.w3.org/2001/XMLSchema#string

Jeong-A Park

http://www.w3.org/2001/XMLSchema#string

Sangkyu Park

http://www.w3.org/2001/XMLSchema#string

Sukgil Song

http://www.w3.org/2001/XMLSchema#string

Young-Eun Kim

http://www.w3.org/2001/XMLSchema#string

Younghee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Caspase-10 is an initiator caspase in death receptor signaling

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function

Anticancer activities of histone deacetylase inhibitors

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.

P2888

s12192-014-0533-4

P304

149-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12192-014-0533-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25119188

http://www.w3.org/2001/XMLSchema#string

P921

P932

4255254

http://www.w3.org/2001/XMLSchema#string